TrialCancer medicine2020

Palbociclib-letrozole as first-line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study.

Masato Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.